Know Cancer

or
forgot password

Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery


N/A
18 Years
65 Years
Open (Enrolling)
Female
Pain

Thank you

Trial Information

Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery


Inclusion Criteria:



- Gender: Female

- Age: 18-65 years

- Non-pregnant, non-lactating

- Surgery: Outpatient hysteroscopic NovasureĀ® endometrial ablation

- Language: English speaking

- Consent: Obtained

Exclusion Criteria:

- Patient refusal

- Under 18 or over age 65

- Non-English Speaking

- Pregnancy, Breast feeding

- Hysteroscopic procedures using ThermachoiceĀ® ablation device

- Chronic use or addiction to opiates, sedatives, non-opiate analgesics

- History of heavy alcohol usage (>4 drinks/day)

- Significant cardiovascular or pulmonary disease

- Psychiatric or emotional disorder

- Allergy to anesthetic agents utilized in the protocol

- Glaucoma

- Thyrotoxicosis

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Outcome Measure:

Total dose of postoperative opioid

Outcome Description:

Total dose of opioids will be determined for up to 24 hours post operatively

Outcome Time Frame:

24 hours post operatively

Safety Issue:

No

Principal Investigator

Shireen Ahmad, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Northwestern University

Authority:

United States: Institutional Review Board

Study ID:

STU00026695

NCT ID:

NCT01106846

Start Date:

February 2010

Completion Date:

June 2014

Related Keywords:

  • Pain
  • Ketamine
  • Anesthesia
  • Pain
  • Outpatient surgery
  • Adenoma

Name

Location

Northwestern University Chicago, Illinois  60611
Prentice Women's Hosptial Chicago, Illinois  60611